相关实验视频

Updated: Jun 14, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.5K

人类视网膜器官用于模拟与年龄相关的干色斑变性和查药物

Xiaolu Hao1,2, Lu Du1, Guang Liu3

  • 1Senior Department of Ophthalmology, The Third Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

Genes & diseases
|August 21, 2025
PubMed
概括

通过减少细胞死亡和改善视力,甲胺和TN1可以预防与年龄相关的干性黄斑退化 (AMD). 这些治疗可能通过向HMOX1基因,为AMD提供新的治疗策略.

关键词:
干燥的与年龄相关的斑点退化 (AMD)胎儿血红蛋白诱导剂TN1甲胺的使用氧化应激视网膜有机体

更多相关视频

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.7K
Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling06:24

Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling

Published on: July 26, 2024

1.3K

相关概念视频

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...